Vitor Hugo Pastorini Filho in Ocala, Florida

Home Florida Ocala

Vitor Hugo Pastorini Filho has Hematology/oncology as his primary medical specialty. Their primary office is: 4945 Sw 49th Place in Ocala, Florida. There is an additional office location, for a total of two, for Vitor Hugo Pastorini Filho that can be viewed further down.

They're a part of the: Florida Cancer Specialists And Research Institute, Llc medical group which has around 380 members. You can call their office at 352-237-9430 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2008 (around 16 years of experience). They are listed as doing telehealth appointments.

Vitor Hugo A Pastorini Filho Office Phone and Directions

Vitor Hugo Pastorini Filho
Florida Cancer Specialists And Research Institute, Llc
4945 Sw 49th Place
Ocala, Florida 33474
352-237-9430

Patient Ratings
Please rate your experience with Vitor Hugo Pastorini Filho below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 352-237-9430

Enter a starting address:

Healthcare Info for Vitor Hugo Pastorini Filho

Medical School: Sorry, his university is not listed
Graduation Year: 2008
The Primary Medical Specialty for Vitor Hugo Pastorini Filho is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 7618194069
NPI #: 1215165279
NPI Created On: 06/30/2009
NPI Last Updated Listed as: 10/25/2022
Primary Taxonomy Code: 207RH0000X
License Number:
ME147010
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Collection of blood specimen from a completely implantable venous access device
Vaccine for influenza for injection into muscle
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994961

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017531

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795526677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832174331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832174511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783437517

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783437519

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $111

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 812975491

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: OCTAGAM IMMUNE GLOBULIN (HUMAN)

Open Associated Drug #1: 68982-840-01

Additional Office Locations

1. Florida Cancer Specialists And Research Institute, Llc
1630 Se 18th St Building 600
Ocala, FL 34471
602 Florida Cancer Specialists P L
Group Members: 380

Phone: 352-237-9430

Enter a starting address:

Hematology/oncology Professionals in Ocala

1.
Ravi Koti MD

2494 Sw 19th Ave Rd
Ocala, FL
Central Florida Cancer And Blood Center Pa

2.
Andrew Weber

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

3.
Craig Reynolds MD

1630 Se 18th St Building 600
Ocala, FL
Florida Cancer Specialists And Research Institute, Llc

4.
Maury Berger MD

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

5.
Anju Vasudevan MD

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

6.
Anju Vasudevan MD

9401 Sw State Rd
Ocala, FL
Ocala Oncology Center Pl

Providers in Florida Cancer Specialists And Research Institute, Llc

1.Patrick Acevedo Md

1503 Buenos Aires Blvd
The Villages Fl 32159-6823
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

2.Patrick Acevedo Md

6420 W Newberry Rd E Wing
Gainesville Fl 32605-4308
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

3.Patrick Acevedo Md

1396 Whisper Cir
Sebring Fl 33870-1204
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

4.Patrick Acevedo Md

2848 Ctr Pointe Dr
Fort Myers Fl 33916-9521
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

5.Patrick Acevedo Md

901 Tamiami Trl S
Venice Fl 34285-3668
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

6.Patrick Acevedo Md

2231 Hwy 44 West 203
Inverness Fl 34453-3879
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

View all 380 members of Florida Cancer Specialists And Research Institute, Llc medical group